期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

维持性血液透析患者高血压的药物治疗 被引量：5

Drug therapy for hypertension in hemodialysis patients
下载PDF
导出
摘要 高血压是维持性血液透析患者的主要并发症,降压治疗可降低血透患者心血管并发症的发病率及死亡率。血管紧张素转化酶抑制剂(ACEI)、血管紧张素Ⅱ受体阻断剂(ARB)、钙拮抗剂(CCB)和β受体阻断剂等多类降压药物均可用于血透患者的高血压治疗。本文综述近年各类降压药物用于血透患者高血压治疗的疗效及其评价研究。 Hypertension is a main complication in hemodialysis（HD） patients.Drug therapy for hypertension could decrease cardiovascular morbidity and mortality of these patients.Antihypertensive drugs for hemodialysis patients include angiotensin converting enzyme inhibitors（ACEI）,angiotensin Ⅱ receptor blockers（ARB）,calcium-channel blockers（CCB） and beta receptor blockers.This review focuses on drug therapy for hypertension in hemodialysis patients.
作者 张海英 汪年松
机构地区 上海市交通大学附属第六人民医院肾内科
出处 《世界临床药物》 CAS 2011年第5期299-302,共4页 World Clinical Drug
关键词 血液透析 高血压 药物治疗 hemodialysis hypertension drug therapy
分类号 R972.4 [医药卫生—药品] R692.5 [医药卫生—泌尿科学]
  • 相关文献

参考文献20

  • 1MP H(o)rl,M Tepel.Drug therapy for hypertension in hemodialysis patients[J].Minerva Med,2005,96(4):277-85.
  • 2戴兵,梅长林.透析高血压的发病机制及治疗进展[J].中国血液净化,2007,6(1):5-7. 被引量：34
  • 3Martin LC,France RJ,Gavras I,et al.Is 44-hour better than 24-hour ambulatory blood pressure monitoring in hemodialysis?[J].Kidney Blood Press Res,2006,29(5):273-279.
  • 4陈香美,张利.透析患者高血压的治疗策略:我们应从何处开始?[J].中国血液净化,2010,9(2):60-62. 被引量：15
  • 5Davenport A,Cox C,Thuraisingham R.Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension Blood pressure control and intradialytic hypotension[J].Kidney Int,2008,73(6):759-764.
  • 6K/DOQI Workgroup.K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients[J].Am J Kidney Dis,2005,45 (Suppl 3):S1-S153.
  • 7Heerspink HJ,Ninomiya T,Zoungas S,et al.Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis:a systematic review and meta-analysis of randomised controlled trials[J].Lancet,2009,373(9668):S1009-S1015.
  • 8Efrati S,Zaidenstein R,Dishy V,et al.ACE inhibitors and survival of hemodialysis patients[J].Am J Kidney Dis,2002,40(5):1023-1029.
  • 9Zheng S,Nath V,Coyne DW.ACE inhibitor-based,directly observed therapy for hypertension in hemodialysis patients[J].Am J Nephrol,2007,27(5):522-529.
  • 10London GM,Pannier B,Guerin AP,et al.Cardiac hypertrophy,aortic compliance,peripheral resistance,and wave reflection in end-stage renal disease.Comparative effects of ACE inhibition and calcium channel blockade[J].Circulation,1994,90(6):2786-2796.

二级参考文献38

  • 1中国人民解放军肾脏病专业协作组.2001例血液透析患者病因分析及高血压和贫血治疗状况[J].中国血液净化,2005,4(5):235-238. 被引量：77
  • 2吕玉风,刘必成,邢昌赢,张苗,孙伟,楼季庄,张晓良,王艳丽.维持性血液透析合并高血压治疗状况的多中心调查[J].中国血液净化,2007,6(4):184-187. 被引量：18
  • 3Zager PG, Nikolic J, Brown RH, et al. "U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc[T]. Kidney Int, 1998,54: 561-569.
  • 4Port FK, Hulbert-Shearon TE, Wolfe RA,, et al. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients[J].AmJ Kidney Dis, 1999, 33:507-517.
  • 5Heerspink HJ, Ninomiya T, Zoungas S, et al. Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: A systematic review and meta-analysis of randomised controlled trials[J]. Lancet, 2009.373:1009-1015.
  • 6Agarwal R, Sinha AD. Cardiovascular protection with anti- hypertensive drugs in dialysis patients: Systematic review and meta-analysis[J].Hypertension, 2009,53:860-866.
  • 7Stidley CA, Hunt WC, Tentori F, et al. Changing relationship of blood pressure with mortality over time among hemodialysis patients[J].J Am Soc Nephrol, 2006,17:513-520.
  • 8Udayaraj UP, Steenkamp R, Caskey FJ, et al. Blood pressure and mortality risk on peritoneal dialysis[J]. Am J Kidney Dis, 2009,53:70-78.
  • 9Foley RN, Agarwal R. Hypertension is harmful to dialysis patients and should be controlled[J]. Semin Dial,2007,20: 518-522.
  • 10K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients[J]. Am J Kidney Dis, 2005, 45(Suppl 3):S1-S153.

共引文献46

同被引文献34

  • 1黄粤锋,陈钰仪,肖惠珍,陈仁山.高血压联合治疗优化方案探讨[J].中外医疗,2008,27(18):30-31. 被引量：5
  • 2LIU Yi,XU Yu lan,ZHEN Chen fei,WANG Lu ping Blood Detoxification Department ,the First Affiliated Hospital Wenzhou Medical College,Zhejiang province,wenzhou 325000,China.Prevalence of hypertension in a hemodialysis population[J].Chinese Journal of Biomedical Engineering(English Edition),2000,9(3):111-116. 被引量：1
  • 3王梅.高血压与肾脏疾病[J].中国实用内科杂志,2007,27(12):921-923. 被引量：12
  • 4K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardio- vascular disease in dialysis patients[J]. Am J Kidney Dis,2005,45(4 suppl 3):S1-153.
  • 5Davenport A,Cox C,Thuraisingham R. Achieving blood pressure tar- gets during dialysis improves control but increases intradialytic hy- potension blood pressure control and intradialytic hypotension[J]. Kid- ney lnt, 2008,73(6) :759-764.
  • 6Kooman JP,Van der Sande FM,Leunissen KM. Role of sodium and volume in the pathogenesis of hypertension in dialysis patients.Reflec- tions on pathophysiological mechanisms[J]. B l ood Purif,2004,22:55-59.
  • 7Charra B. "Dry weight"in dialysis :the history of a concept[J]. Nephol Dial Transplant, 1998,13:1882-1885.
  • 8Kurajoh [J].Inaba M,Yamada S,et al .Association of increased active PTH (1-84)fraction with decreased GFR and serum Ca in predialysis CRF patients: modulationby serum 25-OH-D[J].Osteoporos Int,2008; 19(5):709 — 716.
  • 9张福康,石壬伟,康志荣,窦芒,胡强燕.终末期肾脏病血液透析患者高血压的药学监护[J].中国药师,2007,10(11):1122-1123. 被引量：5
  • 10卞维静,王国勤,罗洋,付芳婷,张凌,李文歌,谌贻璞.长期血液透析患者继发性甲状旁腺功能亢进症的流行病学分析[J].中日友好医院学报,2008,22(4):195-197. 被引量：37

引证文献5

二级引证文献20

世界临床药物
2011年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部